Disease-Specific Mortality | Variable | HR | 95% CI for HR | P value |
---|---|---|---|---|
Univariable | Regional node (N) | |||
N0 vs N+ | 4.067 | 1.827-9.051 | 0.001 | |
Distant Metastasis (M) | ||||
M0 vs M+ | 3.320 | 1.897-5.809 | <0.0001 | |
Clinical Stage | ||||
I&II vs III&IV | 5.594 | 2.012-15.549 | 0.001 | |
Histological Subtype | ||||
NSCLC vs SCLC | 2.098 | 1.153-3.819 | 0.015 | |
APCme | ||||
Negative vs positive | 2.800 | 1.634-4.800 | <0.0001 | |
FOXA1me | ||||
Negative vs positive | 1.716 | 1.027-2.867 | 0.039 | |
HOXD3me | ||||
Negative vs positive | 1.666 | 0.982-2.828 | 0.058 | |
RASSF1Ame | ||||
Negative vs positive | 2.669 | 1.529-4.660 | 0.001 | |
SEPT9me | ||||
Negative vs positive | 2.011 | 1.130-3.579 | 0.018 | |
SOX17me | ||||
Negative vs positive | 1.696 | 0.991-2.902 | 0.054 | |
APCme / RASSF1Ame | <0.0001 | |||
Both negative vs One positive | 2.582 | 1.428-4.671 | 0.002 | |
Both negative vs Both Positive | 3.958 | 1.967-7.965 | <0.0001 | |
Multivariable | Clinical Stage | |||
I&II vs III&IV | 5.014 | 1.781-14.114 | 0.002 | |
APCme / RASSF1Ame | <0.0001 | |||
Both negative vs One positive | 1.992 | 1.100-3.608 | 0.023 | |
Both negative vs Both positive | 3.918 | 1.935-7.933 | <0.0001 |